Literature DB >> 21600526

Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

Jennifer G Robinson1, Anne C Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21600526     DOI： 10.1016/j.jacl.2011.03.451

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN： 1876-4789            Impact factor:   4.766


× No keyword cloud information.
  24 in total

Review 1.  Familial hypercholesterolemia.

Authors:  Victoria Enchia Bouhairie; Anne Carol Goldberg
Journal:  Cardiol Clin       Date:  2015-05       Impact factor: 2.213

2.  A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.

Authors:  Gerald F Watts; David R Sullivan; Frank M van Bockxmeer; Nicola Poplawski; Ian Hamilton-Craig; Peter M Clifton; Richard C O'Brien; Peter M George; John R Burnett
Journal:  Clin Biochem Rev       Date:  2012-02

Review 3.  Mipomersen sodium: first global approval.

Authors:  Philip Hair; Fiona Cameron; Kate McKeage
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

Review 4.  Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?

Authors:  Ines Krass; Adrian T Walker; Gerald F Watts
Journal:  Int J Clin Pharm       Date:  2012-05-24

Review 5.  Current Treatment of Familial Hypercholesterolaemia.

Authors:  Cameron T Lambert; Pratik Sandesara; Ijeoma Isiadinso; Maria Carolina Gongora; Danny Eapen; Neal Bhatia; Jefferson T Baer; Laurence Sperling
Journal:  Eur Cardiol       Date:  2014-12

6.  Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.

Authors:  Emil M deGoma; Zahid S Ahmad; Emily C O'Brien; Iris Kindt; Peter Shrader; Connie B Newman; Yashashwi Pokharel; Seth J Baum; Linda C Hemphill; Lisa C Hudgins; Catherine D Ahmed; Samuel S Gidding; Danielle Duffy; William Neal; Katherine Wilemon; Matthew T Roe; Daniel J Rader; Christie M Ballantyne; MacRae F Linton; P Barton Duell; Michael D Shapiro; Patrick M Moriarty; Joshua W Knowles
Journal:  Circ Cardiovasc Genet       Date:  2016-03-24

Review 7.  Building evidence and measuring clinical outcomes for genomic medicine.

Authors:  Josh F Peterson; Dan M Roden; Lori A Orlando; Andrea H Ramirez; George A Mensah; Marc S Williams
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

Review 8.  My Approach to the Patient With Familial Hypercholesterolemia.

Authors:  Maya S Safarova; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2016-06       Impact factor: 7.616

9.  Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.

Authors:  Klaus G Parhofer
Journal:  Core Evid       Date:  2012-05-31

Review 10.  Familial hypercholesterolemia: present and future management.

Authors:  B Sjouke; D M Kusters; J J P Kastelein; G K Hovingh
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.